Sign in
TerminatedPhase 1

Pilot - Resistance Exercise for Inpatient Treatment in T2D

Key facts

Who runs it
Copenhagen University Hospital, Rigshospitalet
Where
Denmark2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
Phase
Phase 1
People taking part
4 people enrolled
Started
12 Aug 2024
Ended
20 Mar 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Exercise
Record updated
21 January 2026
Why it stopped
Too low recruitment.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • T2D or prediabetes defined as at least one of the following; ICD-10 diagnosis of T2D (DE11.x); HbA1c > 48 at time of admission; Use of type 2 antidiabetic medicine (excluding SGLT2 inhibitors); HbA1c ≥ 42 within 3 months of admission (prediabetes) (from 18 of September, 2024)
  • Hospitalized with an infection
  • Expected residual hospitalization time of at least three days
  • At least 18 years of age
  • Able to perform exercises in the booklet "Syg men sun dog aktiv"

Who cannot take part

  • Terminal illness
  • Unstable or new onset angina
  • Ventricular arrhythmia
  • Kidney failure requiring dialysis
  • Known allergy or contact dermatitis to tape, and CGMs
  • Admitted to the hospital more than 5 days ago
  • Unable to give written consent to participate
  • Aortic stenosis
  • Sternotomy in conjunction with the current hospitalization
  • Blood pressure greater than 180/120 mmHg
  • Unable to follow the 3-stage command of the Mini-Mental State Examination

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Type 2 Diabetes (T2D) is associated with prolonged hospitalization and an increased risk of readmission. Moreover, sedentary behavior and poor glycemic control may contribute to disease severity and mortality. The inactivity during hospitalization is particularly concerning in T2D patients, due to the negative effect on glucose metabolism and secondary loss of skeletal muscle mass, which can further disrupt glucose regulation. However, there are no exercise guidelines for hospitalized T2D patients. To address this gap, a feasibility study will be conducted examining the effectiveness of incorporating resistance training into hospital care for T2D patients. For the feasibility study, 24 patients with T2D or prediabetes will be recruited from the Department of Infectious Diseases at Rigshospitalet and Hvidovre Hospital and randomized to 4 weeks of resistance training for 30 minutes per day or standard treatment. If the participants are discharged they will be offered online-training sessions. During the hospitalization a continuous glucose monitor will be applied and an accelerometer during the full intervention. At baseline, discharge and at follow-up, extensive testing will be performed.

The 2 groups in the trial

  • ExerciseTreatment being tested

    The exercise intervention is a four-week intervention and will consist of body weight strength training. All training sessions during hospitalization will be supervised and will be performed individually for 30 min/day. If the patient is discharged within the four-week training period, the training will continue from home and will be online-based with a live video connection to an instructor. The training program will be the same. The intervention group will ideally exercise post-prandially (within 60 min following the meal) following either breakfast or lunch. Exercise intensity will be monitored throughout the training (with a heart rate monitor) and patients will estimate the rigorousness of the training using the rate of perceived exertion (RPE)-scale. If possible, the goal is for the patients to reach a minimum of 5, corresponding to moderate intensity, but preferably 7+ on the 0-10 RPE scale in each set. The aim is to complete the training sessions five out of seven days/week.

  • ControlNo study treatment, for comparison

    The Control group will be placed in a chair for 30 minutes, within 60 minutes following either breakfast or lunch daily during admission, depending on other workflows in the ward. This corresponds to the time spent on exercise by the intervention group. The control group will also be in daily contact with the instructor following discharge and will be asked the same daily questions and will be seated in a chair for 30 minutes as during hospitalization.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Exercise Training During Hospitalization in Patients With Type 2 Diabetes - A Phase 1 Trial
Record updated
21 January 2026